Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma

Immune checkpoint inhibitors (ICIs) are currently a first-line treatment option for clear cell renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large number of patients do not respond to ICIs. Moreover, only a few patients achieve a stable and durable response even wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Enyu, Liu, Xuechao, Liu, Yanjun, Zhang, Zedan, Xie, Lu, Tian, Kaiwen, Liu, Jiumin, Yu, Yuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970116/
https://www.ncbi.nlm.nih.gov/pubmed/33746989
http://dx.doi.org/10.3389/fimmu.2021.653358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970116/
https://www.ncbi.nlm.nih.gov/pubmed/33746989
http://dx.doi.org/10.3389/fimmu.2021.653358

Ejemplares similares